These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2004-005019-28||Diabetes therapy to improve body mass index pulmoanry function in cystic fibrosis subjects with abnormal blood glucose||not-yet-due|
|Ongoing||2009-011543-40||Assessment of platelet inhibitory response to clopidogrel when coadministered with a proton pump inhibitor||not-yet-due|
|Not reported||2010-018435-18||Assessing Platelet Inhibitory Response to Clopidogrel – Feasibility, Safety and Cost Analysis of a Tailored Platelet Inhibition Strategy for Elective PCI Patients||2012-09-03||due-trials|
|Ongoing||2010-023355-29||Tyrosine kinase Inhibitors in DysplAsia of Lung epithelium Study 1||not-yet-due|
|Not reported||2011-001121-24||Prospective randomised controlled trial of video assisted thorascopic (VATS) cytoreductive pleurectomy compared to talc pleurodesis in patients with suspected or proven malignant mesothelioma||2013-05-02||due-trials|
|Ongoing||2013-001967-22||A phase II study to investigate the protective effects of Glucagon-like Peptide-1 (GLP-1) in patients undergoing elective angioplasty and stenting.||not-yet-due|
|Ongoing||2014-001277-14||A Randomised Mechanistic Study Comparing the Effects of Different Anti-platelet Combinations (Ticagrelor vs. Placebo/ Clopidogrel) with Aspirin in Patients presenting with STEMI Treated with Primary P...||not-yet-due|
|Ongoing||2014-001950-41||The effect of acute intravenous (iv) morphine administration on Sleep Disordered Breathing (SDB) in patients with moderate Obstructive Sleep Apnoea (OSA): A paired design trial||not-yet-due|
|Ongoing||2015-002799-26||TRANSFORM-UK: A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension||not-yet-due|
|Ongoing||2016-000211-33||Dose Effect Relationship of a Single Dose of Rituximab on the Kinetics of B Lymphocytes in Patients with Acute ST-Segment Myocardial Infarction||not-yet-due|